{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:34:47Z","timestamp":1780511687131,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:00:00Z","timestamp":1455580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00066-016-0956-1","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T10:36:21Z","timestamp":1455618981000},"page":"359-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer","Symptomatische strahleninduzierte Herzerkrankung bei Langzeit\u00fcberlebenden nach \u00d6sophaguskarzinom"],"prefix":"10.1007","volume":"192","author":[{"given":"Ichiro","family":"Ogino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenobu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Kosuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Kunisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"key":"956_CR1","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-06-1420","volume":"12","author":"E Brusamolino","year":"2006","unstructured":"Brusamolino E, Baio A, Orlandi E, Arcaini L, Passamonti F, Griva V, Casagrande W, Pascutto C, Franchini P, Lazzarino M (2006) Long-term events in adult patients with clinical stage IA\u2013IIA nonbulky Hodgkin\u2019s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clin Cancer Res 12:6487\u20136493. doi: 10.1158\/1078-0432.CCR-06-1420","journal-title":"Clin Cancer Res"},{"key":"956_CR2","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/1097-0142(197606)37:6<2813::AID-CNCR2820370637>3.0.CO;2-S","volume":"37","author":"RJ Carmel","year":"1976","unstructured":"Carmel RJ, Kaplan HS (1976) Mantle irradiation in Hodgkin\u2019s disease. An analysis of technique, tumor eradication, and complications. Cancer 37:2813\u20132825","journal-title":"Cancer"},{"key":"956_CR3","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","volume":"270","author":"SL Hancock","year":"1993","unstructured":"Hancock SL, Tucker MA, Hoppe RT (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease. JAMA 270:1949\u20131955","journal-title":"JAMA"},{"key":"956_CR4","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","volume":"290","author":"MC Hull","year":"2003","unstructured":"Hull MC, Morris CG, Pepine CJ, Mendenhall NP (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 290:2831\u20132837. doi: 10.1001\/jama.290.21.2831","journal-title":"JAMA"},{"key":"956_CR5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.radonc.2012.04.016","volume":"104","author":"A Konski","year":"2012","unstructured":"Konski A, Li T, Christensen M, Cheng JD, Yu JQ, Crawford K, Haluszka O, Tokar J, Scott W, Meropol NJ, Cohen SJ, Maurer A, Freedman GM (2012) Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiother Oncol 104:72\u201377. doi: 10.1016\/j.radonc.2012.04.016","journal-title":"Radiother Oncol"},{"key":"956_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","volume":"70","author":"X Wei","year":"2008","unstructured":"Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, Komaki R, Liao Z (2008) Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 70:707\u2013714. doi: 10.1016\/j.ijrobp.2007.10.056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"956_CR7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0360-3016(91)90794-5","volume":"21","author":"JM Cosset","year":"1991","unstructured":"Cosset JM, Henry-Amar M, Pellae-Cosset B, Carde P, Girinski T, Tubiana M, Hayat M (1991) Pericarditis and myocardial infarctions after Hodgkin\u2019s disease therapy. Int J Radiat Oncol Biol Phys 21:447\u2013449","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"956_CR8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.clon.2013.06.012","volume":"25","author":"FA Stewart","year":"2013","unstructured":"Stewart FA, Seemann I, Hoving S, Russell NS (2013) Understanding radiation-induced cardiovascular damage and strategies for intervention. Clin Oncol 25:617\u2013624. doi: 10.1016\/j.clon.2013.06.012","journal-title":"Clin Oncol"},{"key":"956_CR9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.20.5.1167","volume":"20","author":"BD Minsky","year":"2002","unstructured":"Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP (2002) INT 0123 (Radiation Therapy Oncology Group 94\u201305) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167\u20131174","journal-title":"J Clin Oncol"},{"key":"956_CR10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(98)00232-6","volume":"42","author":"TJ Smith","year":"1998","unstructured":"Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, Tormey DC, Schutt AJ, Hinson J, Sischy B (1998) Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42:269\u2013276","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"956_CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00066-014-0779-x","volume":"191","author":"AD Ordu","year":"2015","unstructured":"Ordu AD, Nieder C, Geinitz H, Kup PG, Deymann LF, Scherer V, Combs SE, Fakhrian K (2015) Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus: long-term outcome. Strahlenther Onkol 191:153\u2013160. doi: 10.1007\/s00066-014-0779-x","journal-title":"Strahlenther Onkol"},{"key":"956_CR12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1442-2050.2008.00935.x","volume":"22","author":"R Takagawa","year":"2009","unstructured":"Takagawa R, Kunisaki C, Makino H, Kosaka T, Ono HA, Akiyama H, Shimada H (2009) Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus. Dis Esophagus 22:482\u2013489. doi: 10.1111\/j.1442-2050.2008.00935.x","journal-title":"Dis Esophagus"},{"key":"956_CR13","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837\u20131847","journal-title":"Circulation"},{"key":"956_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","volume":"79","author":"M Feng","year":"2011","unstructured":"Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, Hayman JA, Jagsi R, Jolly S, Larouere J, Soriano J, Marsh R, Pierce LJ (2011) Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancerl. Int J Radiat Oncol Biol Phys 79:10\u201318. doi: 10.1016\/j.ijrobp.2009.10.058","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"956_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1009756504168","volume":"1","author":"BM Kaplan","year":"1997","unstructured":"Kaplan BM, Miller AJ, Bharati S, Lev M, Martin Grais I (1997) Complete AV block following mediastinal radiation therapy: electrocardiographic and pathologic correlation and review of the world literature. J Interv Card Electrophysiol 1:175\u2013188","journal-title":"J Interv Card Electrophysiol"},{"key":"956_CR16","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","volume":"21","author":"S Ishikura","year":"2003","unstructured":"Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T, Yoshida S (2003) Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:2697\u20132702. doi: 10.1200\/JCO.2003.03.055","journal-title":"J Clin Oncol"},{"key":"956_CR17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00535-006-1771-8","volume":"41","author":"Y Kumekawa","year":"2006","unstructured":"Kumekawa Y, Kaneko K, Ito H, Kurahashi T, Konishi K, Katagiri A, Yamamoto T, Kuwahara M, Kubota Y, Muramoto T, Mizutani Y, Imawari M (2006) Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol 41:425\u2013432. doi: 10.1007\/s00535-006-1771-8","journal-title":"J Gastroenterol"},{"key":"956_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0360-3016(97)00584-1","volume":"40","author":"MK Martel","year":"1998","unstructured":"Martel MK, Sahijdak WM, Ten Haken RK, Kessler ML, Turrisi AT (1998) Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 40:155\u2013161","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"956_CR19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","volume":"99","author":"AJ Swerdlow","year":"2007","unstructured":"Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister A, Radford JA, Rohatiner AZ, Linch DC (2007) Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 99:206\u2013214. doi: 10.1093\/jnci\/djk029","journal-title":"J Natl Cancer Inst"},{"key":"956_CR20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","volume":"42","author":"PA Heidenreich","year":"2003","unstructured":"Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I (2003) Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42:743\u2013749","journal-title":"J Am Coll Cardiol"},{"key":"956_CR21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10554-009-9440-7","volume":"25","author":"I Gayed","year":"2009","unstructured":"Gayed I, Gohar S, Liao Z, McAleer M, Bassett R, Yusuf SW (2009) The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy. Int J Cardiovasc Imaging 25:487\u2013495. doi: 10.1007\/s10554-009-9440-7","journal-title":"Int J Cardiovasc Imaging"},{"key":"956_CR22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djk064","volume":"99","author":"MJ Hooning","year":"2007","unstructured":"Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE (2007) Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99:365\u2013375. doi: 10.1093\/jnci\/djk064","journal-title":"J Natl Cancer Inst"},{"key":"956_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2014.11.037","volume":"114","author":"JC Beukema","year":"2015","unstructured":"Beukema JC, van Luijk P, Widder J, Langendijk JA, Muijs CT (2015) Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiother Oncol 114:85\u201390. doi: 10.1016\/j.radonc.2014.11.037","journal-title":"Radiother Oncol"},{"key":"956_CR24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijrobp.2008.10.075","volume":"75","author":"M Morota","year":"2009","unstructured":"Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, Ito H, Yamashita T (2009) Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 75:122\u2013128. doi: 10.1016\/j.ijrobp.2008.10.075","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"956_CR25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.meddos.2006.12.003","volume":"32","author":"YJ Chen","year":"2007","unstructured":"Chen YJ, Liu A, Han C, Tsai PT, Schultheiss TE, Pezner RD, Vora N, Lim D, Shibata S, Kernstine KH, Wong JY (2007) Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim 32:166\u2013171. doi: 10.1016\/j.meddos.2006.12.003","journal-title":"Med Dosim"},{"key":"956_CR26","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2012.02.015","volume":"84","author":"SH Lin","year":"2012","unstructured":"Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z (2012) Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 84:1078\u20131085. doi: 10.1016\/j.ijrobp.2012.02.015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-016-0956-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-016-0956-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-016-0956-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:30:59Z","timestamp":1558564259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-016-0956-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["956"],"URL":"https:\/\/doi.org\/10.1007\/s00066-016-0956-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,16]]}}}